Hologic, Inc. (NASDAQ: HOLX) closed the day trading at $73.65 down -0.20% from the previous closing price of $73.80. In other words, the price has decreased by -$0.15 from its previous closing price. On the day, 1358025 shares were traded. HOLX stock price reached its highest trading level at $74.50 during the session, while it also had its lowest trading level at $73.17.
Ratios:
For a better understanding of HOLX, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 8.95 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.13. For the most recent quarter (mrq), Quick Ratio is recorded 3.18 and its Current Ratio is at 3.89. In the meantime, Its Debt-to-Equity ratio is 0.55 whereas as Long-Term Debt/Eq ratio is at 0.55.
On December 07, 2022, RBC Capital Mkts started tracking the stock assigning a Sector Perform rating and target price of $75.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $75.Mizuho initiated its Buy rating on October 13, 2022, with a $75 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 29 when Oberton Karleen Marie sold 14,940 shares for $75.00 per share. The transaction valued at 1,120,500 led to the insider holds 103,916 shares of the business.
Dockendorff Charles J sold 16,017 shares of HOLX for $1,153,224 on Jan 02. The Director now owns 1,465 shares after completing the transaction at $72.00 per share. On Dec 11, another insider, GARRETT SCOTT T, who serves as the Director of the company, sold 10,000 shares for $68.71 each. As a result, the insider received 687,116 and left with 47,039 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, HOLX now has a Market Capitalization of 17.29B and an Enterprise Value of 17.93B. As of this moment, Hologic,’s Price-to-Earnings (P/E) ratio for their current fiscal year is 35.01, and their Forward P/E ratio for the next fiscal year is 16.71. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.50. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.36 while its Price-to-Book (P/B) ratio in mrq is 3.71. Its current Enterprise Value per Revenue stands at 4.52 whereas that against EBITDA is 16.87.
Stock Price History:
Over the past 52 weeks, HOLX has reached a high of $87.88, while it has fallen to a 52-week low of $64.02. The 50-Day Moving Average of the stock is 73.28, while the 200-Day Moving Average is calculated to be 74.02.
Shares Statistics:
Over the past 3-months, HOLX traded about 1.87M shares per day on average, while over the past 10 days, HOLX traded about 1.78M shares per day. A total of 241.71M shares are outstanding, with a floating share count of 231.14M. Insiders hold about 1.53% of the company’s shares, while institutions hold 98.23% stake in the company. Shares short for HOLX as of Feb 15, 2024 were 4.39M with a Short Ratio of 2.34, compared to 5.62M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 1.87% and a Short% of Float of 2.80%.
Earnings Estimates
Current recommendations for the stock of the company come from 14 analysts. On average, analysts expect EPS of $0.98 for the current quarter, with a high estimate of $1.02 and a low estimate of $0.96, while EPS last year was $1.06. The consensus estimate for the next quarter is $1.02, with high estimates of $1.05 and low estimates of $0.99.
Analysts are recommending an EPS of between $4.09 and $3.95 for the fiscal current year, implying an average EPS of $4.03. EPS for the following year is $4.39, with 17 analysts recommending between $4.55 and $4.18.
Revenue Estimates
Based on 17 analysts’ estimates, the company’s revenue will be $4.24B in the next fiscal year. The high estimate is $4.32B and the low estimate is $4.08B. The average revenue growth estimate for next year is up 5.40% from the average revenue estimate for this year.
